N.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
JSC Russian Research Center for Molecular Diagnostics and Therapy, 117149 Moscow, Russia.
Int J Mol Sci. 2021 Nov 12;22(22):12261. doi: 10.3390/ijms222212261.
The selection of technological parameters for nanoparticle formulation represents a complicated development phase. Therefore, the statistical analysis based on Box-Behnken methodology is widely used to optimize technological processes, including poly(lactic-co-glycolic acid) nanoparticle formulation. In this study, we applied a two-level three-factor design to optimize the preparation of nanoparticles loaded with cobalt (CoTPP), manganese (MnClTPP), and nickel (NiTPP) metalloporphyrins (MeP). The resulting nanoparticles were examined by dynamic light scattering, X-ray diffraction, Fourier transform infrared spectroscopy, MTT test, and hemolytic activity assay. The optimized model of nanoparticle formulation was validated, and the obtained nanoparticles possessed a spherical shape and physicochemical characteristics enabling them to deliver MeP in cancer cells. In vitro hemolysis assay revealed high safety of the formulated MeP-loaded nanoparticles. The MeP release demonstrated a biphasic profile and release mechanism via Fick diffusion, according to release exponent values. Formulated MeP-loaded nanoparticles revealed significant antitumor activity and ability to generate reactive oxygen species. MnClTPP- and CoTPP-nanoparticles specifically accumulated in tissues, preventing wide tissue distribution caused by long-term circulation of the hydrophobic drug. Our results suggest that MnClTPP- and CoTPP-nanoparticles represent the greatest potential for utilization in in anticancer therapy due to their effectiveness and safety.
纳米粒子制剂的技术参数选择代表了一个复杂的开发阶段。因此,基于 Box-Behnken 方法学的统计分析被广泛用于优化工艺过程,包括聚(乳酸-共-乙醇酸)纳米粒子制剂。在这项研究中,我们应用了两水平三因子设计来优化负载钴(CoTPP)、锰(MnClTPP)和镍(NiTPP)金属卟啉(MeP)的纳米粒子的制备。通过动态光散射、X 射线衍射、傅里叶变换红外光谱、MTT 试验和溶血活性测定来检查所得纳米粒子。对纳米粒子制剂的优化模型进行了验证,所得纳米粒子具有球形形状和理化特性,使其能够在癌细胞中递送 MeP。体外溶血试验表明,所制备的 MeP 负载纳米粒子具有很高的安全性。根据释放指数值,MeP 的释放表现出两相曲线和 Fick 扩散释放机制。负载 MeP 的纳米粒子表现出显著的抗肿瘤活性和生成活性氧的能力。MnClTPP-和 CoTPP-纳米粒子特别在组织中积累,防止了疏水性药物长期循环引起的广泛组织分布。我们的结果表明,由于 MnClTPP-和 CoTPP-纳米粒子的有效性和安全性,它们在抗癌治疗中具有最大的应用潜力。